| Literature DB >> 23616126 |
S Doi1, I Yasuda, H Kawakami, T Hayashi, H Hisai, A Irisawa, T Mukai, A Katanuma, K Kubota, T Ohnishi, S Ryozawa, K Hara, T Itoi, K Hanada, K Yamao.
Abstract
BACKGROUND AND STUDY AIMS: No prospective comparison of endoscopic ultrasonography-guided direct celiac ganglia neurolysis (EUS - CGN) vs. EUS-guided celiac plexus neurolysis (EUS - CPN) has been reported. The aim of the current study was to compare the effectiveness of EUS - CGN and EUS - CPN in providing pain relief from upper abdominal cancer pain in a multicenter randomized controlled trial. PATIENTS AND METHODS: Patients with upper abdominal cancer pain were randomly assigned to treatment using either EUS - CGN or EUS - CPN. Evaluation was performed at Day 7 postoperatively using a pain scale of 0 to 10. Patients for whom pain decreased to ≤ 3 were considered to have a positive response, and those experiencing a decrease in pain to ≤ 1 were considered to be completely responsive. Comparison between the two groups was performed using intention-to-treat analysis. The primary endpoint was the difference in treatment response rates between EUS - CGN and EUS - CPN at postoperative Day 7. Secondary endpoints included differences in complete response rates, pain scores, duration of pain relief, and incidence of adverse effects.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23616126 DOI: 10.1055/s-0032-1326225
Source DB: PubMed Journal: Endoscopy ISSN: 0013-726X Impact factor: 10.093